|
|||||
|
|
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer |
|
| Authors: | Pegram Mark D Pienkowski Tadeusz Northfelt Donald W Eiermann Wolfgang Patel Ravi Fumoleau Pierre Quan Eleonor Crown John Toppmeyer Deborah Smylie Michael Riva Alessandro Blitz Sandra Press Michael F Reese David Lindsay Mary-Ann Slamon Dennis J |
| Affiliation: | Oncology Research Network, David Geffen School of Medicine, and Division of Hematology/Oncology, University of California, Los Angeles 90095-7077, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |